Cellular Pathology Landscape: A Closer Look at the USUS$ 78 Billion Projection by 2033

Comments ยท 196 Views

This robust market expansion suggests a significant upward trajectory, driven by various factors such as technological advancements, increasing healthcare awareness, and evolving diagnostic practices.

The worldwide cellular pathology market was estimated to be valued US$ 32.7 billion in 2022 and is projected to reach US$ 78.3 billion in 2033. Services led the global product and services market in 2022 with a value share of over 48.0%. They are expected to rise at a CAGR of over 7.5% between 2023 and 2033.

Cellular pathology is a diagnostic service that examines tissue specimens collected from patients during surgical procedure or post-mortem examination. Cellular pathology deals with the microscopic analysis of tissue samples and cells. Under this, sample preparation and processing includes fixation, staining, sectioning and slide mounting, using equipment such microtomes and cryostats. The cellular pathology is sometimes used as a synonym for cytopathology.

Unleash the extraordinary. Claim your sample for unmatched efficiency:

https://www.futuremarketinsights.com/reports/sample/rep-gb-6869

The process is carried out if a patient contains a wellness, inflammation, a cancer or a non-cancerous growth, by observing the means that the cells are organized. Histopathology and cytopathology are key diagnostic tests in the initial detection and diagnosis of cancer and other diseases supported by modern molecular techniques. Cellular pathologists are able to provide information on prognosis and help to appropriately direct therapies in post diagnostic treatment.

The cellular pathology service providers provides routine histopathological diagnosis using both standard techniques and advanced diagnostics including immunocytochemistry, fluorescent in-situ hybridisation (FISH), and polymerase chain reaction (PCR), using electron microscopy. Neuropathology is another diagnostic service, provides a specialist histopathology service. Most specimens are brain- and spinal cord tumours and epilepsy lobectomies. Diagnostic biopsies are peripheral nerves and muscle biopsies, CSF cytology and serum screening for anti-neuronal antibodies.

Cellular Pathology Market: Dynamics

The Cellular pathology market is expected to mark a significant growth in the coming few years due to high probability of increase in number of cancer patient. Histopathology and cytopathology have been the main tools utilized in the diagnosis of cancer. The increased demand for pathology services is one of the major driving factor. Addition to this, government support and technological advancement are also boosting the growth of this market.

However, there are some restraining factors which are restricting the growth of this market. Such as to comply with guidelines for cancer case reporting and with the various recommendations of specimen handling and additional testing, the need to improve turnaround time as a critical element in clinical management; and the need to comply with the statutory requirements of the various laboratory accreditation and quality assurance regulatory bodies.

Cellular Pathology Market: Overview

The global market for Cellular pathology market is expected to witness high growth over the forecast period. The high demand of Histopathology diagnosis due to increasing number of cancer patients. Histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, in clinical medicine. The specimen has been processed and histological sections have been placed onto glass slides. This diagnosis provides the exact results of presence of disease in body. This is very necessary process to avoid error arising in the diagnostic phase, among the clinician and the pathologists.

In developed countries, scientists and health researchers are addressing the threat of cancer to humans by attempting to provide appropriate service to end users.

Key Companies:

• Leica Biosystems Nussloch GmbH (Danaher Corporation)

• BioGenex

• Hologic, Inc.

• Epredia

• Sakura Finetek

• F. Hoffmann-La Roche Ltd.

• Merck KGaA

• Gestalt Diagnostics

• Carl Zeiss AG

• Olympus Corporation

• Abbott Laboratories Inc.

• NeoGenomics Laboratories

Key Segments:

By Product:

• Instruments

• Microtomes & Cryostat

• Pathology Workstations

• Slide Strainers

• Tissue Processers

• Other Instruments

• Consumables

• Fixation Solutions and Stains

• Glass Slides & Cover Slips

• Sample Chambers

• Cassettes

• Reagents & Antibodies

• Probes & Kits

• Other Consumables

• Services

• Cytopathology

• Histopathology

By Application:

• Disease Diagnosis

• Drug Discovery and Development

• Therapeutic Research

By End User:

• Hospitals

• Diagnostic Laboratories

• Academic Research Institutes

By Region:

• North America

• Latin America

• Europe

• South Asia

• East Asia

• Oceania

• Middle East and Africa

Comments